Synchrony is offered with SynX, a cloud-based app compliant with HIPAA and GDPR standards.

Shares of Stereotaxis rose after the company said its Synchrony system had received clearance from the Food and Drug Administration. Shares were up 5.4% to $1.97 in Monday morning trading. The stock ...

The St. Louis-based developer of surgical robotic technology for minimally invasive endovascular intervention designed its ...

The “90-minute CEO” is a design principle: for building your day around leadership blocks long enough to do real thinking and ...

The easiest mistake people make with mobile live dealer games is judging quality by still images. A sharp screenshot can ...

Stocks overcame early losses to finish with slim gains and close out their first winning week since the start of the Iran war ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...